Right Heart Catheterization Protocol: Procedure, Hemodynamic Measurements, and Fick Cardiac Output

Right heart catheterization (RHC) is an invasive diagnostic procedure that involves advancing a specialized catheter through the central venous system and right-sided cardiac chambers into the pulmonary vasculature to directly measure intracardiac pressures and cardiac output. First developed in the 1940s and refined with the introduction of the Swan-Ganz balloon-tipped catheter in 1970, RHC remains the reference standard for hemodynamic evaluation in heart failure, pulmonary hypertension, valvular heart disease, and cardiogenic shock. The procedure provides data that cannot be reliably obtained through noninvasive imaging alone, including right atrial (RA) pressure, right ventricular (RV) pressure, pulmonary artery (PA) pressure, and pulmonary capillary wedge pressure (PCWP).

Indications for right heart catheterization include the evaluation of unexplained dyspnea when noninvasive testing is inconclusive, confirmation and classification of pulmonary hypertension according to hemodynamic criteria, assessment of valvular heart disease severity, pre-transplant hemodynamic evaluation, and management of acute decompensated heart failure or cardiogenic shock. RHC is also essential for vasoreactivity testing in patients with suspected pulmonary arterial hypertension (PAH) and for guiding the titration of inotropic, vasodilator, and mechanical circulatory support therapies in the intensive care unit.

Contraindications to RHC are relatively few and include mechanical tricuspid or pulmonary valve prostheses (which may be damaged by catheter passage), active right-sided endocarditis with large vegetations, and severe uncorrected coagulopathy. Relative contraindications include the presence of a permanent pacemaker or defibrillator leads in the right heart, though experienced operators routinely navigate catheters alongside intracardiac leads with fluoroscopic guidance. The overall complication rate of RHC is low — typically less than 1% for serious adverse events — making it a safe procedure when performed by trained operators following standardized protocols.

The right internal jugular vein is the preferred access site for RHC because it provides a direct anatomic path to the right atrium through the superior vena cava, facilitating catheter manipulation and fluoroscopic positioning. The femoral vein is an alternative when internal jugular access is contraindicated or technically challenging, though it is associated with slightly higher infection risk and requires longer catheter lengths. Subclavian venous access, while sometimes used, carries a higher risk of pneumothorax and is generally avoided for routine hemodynamic studies. Vascular access is obtained using the modified Seldinger technique under ultrasound guidance, and a venous introducer sheath (typically 7–8 French) is placed to accommodate the pulmonary artery catheter.

The standard Swan-Ganz pulmonary artery catheter is a 7-French, 110-cm, balloon-tipped, flow-directed catheter with multiple lumens. After insertion through the introducer sheath, the catheter is advanced with the balloon deflated to approximately 20 cm (right atrium from the right internal jugular approach). The balloon is then inflated with 1.0–1.5 mL of air, and the catheter is advanced under continuous pressure waveform monitoring. As the catheter traverses the right atrium, right ventricle, and pulmonary artery, characteristic pressure waveforms confirm the catheter tip position at each station. Fluoroscopic guidance is used in most catheterization laboratories, although bedside placement guided solely by pressure waveforms is performed in ICU settings.

Proper catheter positioning is confirmed by the transition from the pulmonary artery waveform to the pulmonary capillary wedge waveform upon balloon inflation, with the wedge tracing showing characteristic atrial-type oscillations (a and v waves) and a mean pressure lower than the mean PA pressure. After recording the wedge pressure, the balloon is deflated and the catheter tip should return to a main pulmonary artery position. The catheter must not remain in the wedge position with the balloon inflated for more than 15–30 seconds to avoid pulmonary artery rupture or infarction. Once positioned, the catheter is secured at the introducer hub and a sterile dressing is applied over the insertion site.

Right atrial pressure (RAP) is the first measurement obtained during catheter advancement, with normal values ranging from 2 to 8 mmHg (mean). The RA waveform contains a wave (atrial contraction), x descent (atrial relaxation), v wave (passive atrial filling during ventricular systole), and y descent (early diastolic emptying). Elevated RAP suggests right ventricular dysfunction, tricuspid regurgitation, pericardial constriction, or volume overload. Prominent v waves in the RA tracing are a hallmark of significant tricuspid regurgitation, and equalization of diastolic pressures across all chambers raises suspicion for cardiac tamponade or constrictive pericarditis.

Right ventricular pressure is recorded as the catheter crosses the tricuspid valve, with normal systolic RV pressure of 15–30 mmHg and diastolic pressure of 2–8 mmHg. The catheter is then advanced into the pulmonary artery, where normal PA systolic pressure ranges from 15 to 30 mmHg, diastolic pressure from 4 to 12 mmHg, and mean PA pressure (mPAP) from 9 to 18 mmHg. An mPAP greater than 20 mmHg at rest defines pulmonary hypertension according to the 2022 ESC/ERS guidelines. The PCWP, obtained by balloon inflation in a distal PA branch, reflects left atrial pressure and normally ranges from 6 to 12 mmHg. A PCWP above 15 mmHg indicates elevated left-sided filling pressures, differentiating post-capillary from pre-capillary pulmonary hypertension.

During the hemodynamic study, blood samples are drawn from the PA (mixed venous blood) and a peripheral artery for oxygen saturation analysis. These saturations are critical for both Fick cardiac output calculation and shunt detection. An oxygen saturation step-up greater than 7% between the right atrium and pulmonary artery suggests a left-to-right intracardiac shunt (e.g., atrial septal defect). Thermodilution cardiac output is measured simultaneously by injecting cold saline through the proximal port and recording the temperature change at the distal thermistor, generating a thermodilution curve from which cardiac output is computed. All measurements should be obtained at end-expiration to minimize the effects of intrathoracic pressure variation on recorded values.

The Fick method for cardiac output determination is performed during RHC by simultaneously measuring oxygen consumption (VO₂) and the arteriovenous oxygen content difference (CaO₂ − CvO₂). Arterial blood is drawn from a radial or femoral arterial line, and mixed venous blood is obtained from the distal port of the PA catheter positioned in the main pulmonary artery. Both samples undergo co-oximetry to determine SaO₂ and SvO₂ (mixed venous oxygen saturation), and hemoglobin concentration is measured concurrently. Oxygen content for each sample is calculated using the formula: O₂ content = (1.34 × Hb × SO₂) + (0.003 × PO₂).

Direct VO₂ measurement using a metabolic cart (indirect calorimetry) provides the most accurate Fick cardiac output, but is technically demanding and not universally available. In practice, many laboratories estimate VO₂ using the assumed Fick method, applying body surface area-based formulas such as 125 mL O₂/min/m² (LaFarge and Miettinen) or 3 mL O₂/min/kg. While the assumed Fick method is convenient, it introduces error of 10–25% compared to measured VO₂, particularly in critically ill patients, obese individuals, and those with abnormal metabolic states. The resulting cardiac output is calculated as CO = VO₂ / (CaO₂ − CvO₂), expressed in liters per minute.